These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1098350)

  • 21. Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.
    Nieschlag E; Mauss J; Coert A; Kićović P
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):366-74. PubMed ID: 1173495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
    Savkovic S; Lim S; Jayadev V; Conway A; Turner L; Curtis D; Goebel C; Handelsman DJ
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2277-2283. PubMed ID: 29584875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone undecanoate in the treatment of male hypogonadism.
    Edelstein D; Basaria S
    Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate.
    Tschöp M; Behre HM; Nieschlag E; Dressendörfer RA; Strasburger CJ
    Clin Chem Lab Med; 1998 Apr; 36(4):223-30. PubMed ID: 9638347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
    Schubert M; Bullmann C; Minnemann T; Reiners C; Krone W; Jockenhövel F
    Horm Res; 2003; 60(1):21-8. PubMed ID: 12792150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oral lipidic native testosterone formulation that is absorbed independent of food.
    Newell-Price J; Huatan H; Quirke J; Porter J; Daniel E; Mumdzic E; Voet B; Keevil B; Whitaker MJ; Ross RJ
    Eur J Endocrinol; 2021 Oct; 185(5):607-615. PubMed ID: 34379604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral testosterone undecanoate in hypogonadal male patients.
    Franchimont P; Kicovic PM; Mattei A; Roulier R
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):313-20. PubMed ID: 102469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen replacement therapy: present and future.
    Gooren LJ; Bunck MC
    Drugs; 2004; 64(17):1861-91. PubMed ID: 15329035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral testosterone-triglyceride conjugate in rabbits: single-dose pharmacokinetics and comparison with oral testosterone undecanoate.
    Amory JK; Scriba GK; Amory DW; Bremner WJ
    J Androl; 2003; 24(5):716-20. PubMed ID: 12954663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.
    Behre HM; Abshagen K; Oettel M; Hübler D; Nieschlag E
    Eur J Endocrinol; 1999 May; 140(5):414-9. PubMed ID: 10229906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections.
    Handelsman DJ; Desai R; Conway AJ; Shankara-Narayana N; Stuckey BGA; Inder WJ; Grossmann M; Yeap BB; Jesudason D; Ly LP; Bracken K; Wittert GA
    Eur J Endocrinol; 2022 Jan; 186(3):307-318. PubMed ID: 35000898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.
    Aversa A; Bruzziches R; Francomano D; Spera G; Lenzi A
    J Endocrinol Invest; 2010 Dec; 33(11):776-83. PubMed ID: 20220293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.
    Morales A; Johnston B; Heaton JP; Lundie M
    J Urol; 1997 Mar; 157(3):849-54. PubMed ID: 9072584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
    Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
    J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
    Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
    J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing circulating androgens with oral testosterone undecanoate in eugonadal men.
    Davidson DW; O'Carroll R; Bancroft J
    J Steroid Biochem; 1987 Jun; 26(6):713-5. PubMed ID: 3613571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume.
    Pechersky AV; Mazurov VI; Semiglazov VF; Karpischenko AI; Mikhailichenko VV; Udintsev AV
    Int J Androl; 2002 Apr; 25(2):119-25. PubMed ID: 11903662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men.
    Schürmeyer T; Wickings EJ; Freischem CW; Nieschlag E
    Acta Endocrinol (Copenh); 1983 Mar; 102(3):456-62. PubMed ID: 6402875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral testosterone, a reappraisal.
    Daggett PR; Wheeler MJ; Nabarro JD
    Horm Res; 1978; 9(3):121-9. PubMed ID: 640576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.